DSpace logo
Please use this identifier to cite or link to this item: http://172.20.40.131:8080/jspui/handle/123456789/335
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMistry, Ruchi-
dc.contributor.authorDesai, Dinesh G.-
dc.contributor.authorSeth, Avinash-
dc.date.accessioned2019-07-22T04:52:38Z-
dc.date.available2019-07-22T04:52:38Z-
dc.date.issued2015-10-
dc.identifier.urihttp://localhost:80/xmlui/handle/123456789/335-
dc.description.abstractValidation of product should be performed as per the protocol. The protocol describes the process stages, control variables & measuring responses with justification, sampling plan, acceptance criteria, summary& conclusion. During the validation, samples were withdrawn according to sampling plan. The manufacturing of orodispersible carbamazepine tablet 100 mg by direct compression was validated successfully considering the following parameters. Mixing performed in a planetary mixture for 5, 10 and 15 min at slow speed. Mix blend were sifted through 40 mesh sieve using vibratory sifter. Compression was performed on a 12 station compression machine at 13, 18, 22, 28 RPM. All the analytical data derived during process validation of carbamazepine 100 mg tablet. Hence the process is validated.en_US
dc.language.isoen_USen_US
dc.publisherPharma Science Monitoren_US
dc.subjectCarbamazepineen_US
dc.subjectProcess Validationen_US
dc.subjectOrodispersibleen_US
dc.subjectDirect Compressionen_US
dc.titleProspective Validation of Tablet Manufacturing Process of Orodispersible Tablets by Direct Compressionen_US
dc.typeArticleen_US
Appears in Collections:Faculty Publications

Files in This Item:
File Description SizeFormat 
20160101013958_07_ruchi.pdf290.42 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.